MELD-Na模型评分对评估肝硬化食管胃底静脉曲张出血患者短期预后的临床价值

doi:10.3969/j.issn.1672-5069.2011.02.017

Abstract

Abstract: Objective To evaluate the clinical value of Child-Pugh，model of end-stage liver disease （MELD），and the MELD-Na model in the short-term predicting the rebleeding in patients of decompensated liver cirrhosis with esophageal-gastric varices bleeding（EGVB）. Methods The patients were graded with MELD， Child-Pugh and MELD-Na and observed their rebleeding and mortality；The accuracy of the three models on predicting survival were analyzed using the area under the receiver operating characteristic（ROC）curve（AUC）. Results 49 patients（52.13%）had re-bleeding within 3 months；the Child-Pugh，MELD and MELD-Na scores in patients with re-bleeding and non-bleeding were not significantly different；15 patients died within 3 months，whose MELD-Na score（26.6412.50）was higher than those of survivors（20.354.54，P<0.001）；In determining the prognosis of patients with ROC curve AUC comparison，Child-Pugh classification（0.703）>MELD-Na score（0.661）>MELD score（0.627）. Conclusion Child-Pugh score，MELD score and MELD-Na score can effectively predict the short-term prognosis of patients with decompensated liver cirrhosis，but can not predict the short-term rebleeding.

Key words: Decompensated liver cirrhosis, Esophageal-gastric varices bleeding, MELD, Child-Pugh

FANG Nianfu，ZENG Jing，CHEN Fei，et al.. The short-term prognostic value of the model for end-stage liver disease including serum sodium in liver cirrhosis patients with esophageal-gastric varices bleeding[J]. JOURNAL OF PRACTICAL HEPATOLOGY, 2011, 14(2): 129-131.

References

[1] FORMAN LM，LUCEY MR. Predicting the prognosis of chronic liver disease：an evolution from child to MELD[J]. Hepatology，2001，33（2）:473-475.
[2] KAMATH PS，WIESNER RH，MALINCHOC M，et al. A model to predict survival in patients with end-stage liver disease[J].Hepatology，2001，33（2）:464-470.
[3] BIGGINS SW，KIM WR，TERRAULT NA，et al. Evidence based incorporation of serum sodium concentration into MELD[J]. Gastroenterology，2006，130（6）:1652-1660.
[4] 中华医学会传染病与寄生虫病学分会、肝病学分会. 病毒性肝炎防治方案[J]. 中华肝脏病杂志，2000，8（6）：324-329.
[5] 叶任高. 内科学[M]. 北京：人民卫生出版社，2004：448.
[6] PAPATHEODORIDIS GV，CHOLONGITAS E，DIMITRIADOU E，et al. MELD vs Child-Pugh and creatinine-modified Child-Pugh score for predicting survival in patients with decompensated cirrhosis[J]. Word J Gastroenterol，2005，11: 3099-3104.
[7] RUF AE，KREMERS WK，CHAVEZ LL，et a1. Addition of serum sodium into the MELD score predicts waiting list mortality better than MELD alone[J]. Liver Transplant，2005，11（3）:336-343．
[8] 刘菲，蔡玲燕，陈锡美. 肝功能评估模型的演变[J]. 国际消化杂志，2009，29（4）：268-270.
[9] STRAHL S，MAIER KP. Risk-classification in liver cirrhosis[J]. Praxis（Bern1994），2006，95:1275-1281.
[10] KAMATH PS，KIM WR. The internation normalized ratio of prothrombin time in the model for end-stage liver disease score:a reliable measure[J]. Clin Liver Dis，2009，13（1）:63-66.
[11] BATTA F，GIANNINI E，ROMAGNOLI P，et al. MELD scoring system is useful of predicting prognosis is patients with liver cirrhosis and is correlated with residual liver function:a European study[J]. Gut，2003，52（1）:134-139.
[12] 马慧，王豪，孙焱，等. 失代偿期肝硬化患者的终末期肝病模型预后分析[J]. 中华肝脏病杂志，2005，13（6）：407-409.
[13] 吕晓辉，刘红波，宋敏，等. 终末期肝病模型对失代偿期肝硬化患者预后的回顾性分析[J]. 世界华人消化杂志，2007，15（9）：960-963.
[14] KIM WR，BIGGINS SW，KREMERS WK，et al. Hyponatremia and mortality among patients on the liver-transplant waiting list[J]. N Engl J Med，2008，359（10）:1018-1026.
[15] LUCA A，ANGERMAYR B，BERTOLINI G，et al. An integrated MELD model including serum sodium and age improves the prediction of early mortality in patients with cirrhosis[J]. Liver Transplant，2007，13（8）:1174-1180.
[16] 郑盛，殷芳，严晓会，等. MELD-NA模型评分对评估失代偿期肝硬化患者短期预后的临床价值[J]. 实用肝脏病杂志，2009，12（2）：118-120.
[17] CHALASANI N，KAHI C，FRANCOIS F，et al. Improved patient survival after acute variceal bleeding:a multicenter cohort study[J]. Am J Gastroenterol，2003，98:653.
[18] OBSTEIN KL，CAMBECL MS， REDDY KR，et al. Association between model for end-stage liver disease and spontaneous bacterial peritonitis[J]. Am J Gastroenterol，2007，102（9）:2732.
[19] 申振宇，蒋晓峰，周莹群，等. 肝硬化食管胃底静脉破裂出血患者的MELD评分与预后分析[J]. 同济大学学报（医学版），2009，30（5）：119-120.
[20] BAMBHA K，KIM WR，PEDERSEN R，et al. Predictor of early rebleeding and mortality after acute variceal haemorrhage in patients with cirrhosis[J]. Gut，2008，57（6）:814-820.
[21] FLORES-RENDN AR，GONZLEZ-GONZLEZ JA，GARCA-COMPEAN D，et al. Model for end stage of liver disease （MELD）is better than the Child-Pugh score for predicting in-hospital mortality related to esophageal variceal bleeding[J]. Ann Hepatol，2008，7:230.
[22] GARCIA-TSAO G，SANAYAL AJ，GRACE ND，et al.Prevention and management of gastroesophageal varices and varices hemorrhage in cirrhosis[J]. Am J Gastroenterol，2007，102（9）:2086-2102.
[23] 杨方，王彬彬，李兴海，等. Logistic回归分析肝硬化食管胃底静脉曲张破裂出血的相关因素[J]. 临床肝胆病杂志，2006，22（4）：269-270.

The short-term prognostic value of the model for end-stage liver disease including serum sodium in liver cirrhosis patients with esophageal-gastric varices bleeding

PDF (PC)

Knowledge

Abstract

Cite this article

share this article

References

Related Articles 12

Recommended Articles

Metrics

Comments

[1]	Meng Shurong, Wang Shanshan. Serum B7-H3 and IL-18 levels in patients with hepatitis B liver cirrhosis [J]. JOURNAL OF PRACTICAL HEPATOLOGY, 2019, 22(2): 224-227.
[2]	Zhang Yanhong, Li You, Chen Long, et al. Etiology and complications in 2890 patients with liver cihhrosis [J]. JOURNAL OF PRACTICAL HEPATOLOGY, 2018, 21(3): 344-347.
[3]	Zhao Yu, Zhu Yu, Zhang Daizhong. Efficacy of intrahepatic transplantation of human umbilical cord mesenchymal stem cells combined with matrine in the treatment of patients with decompensated hepatitis B cirrhosis [J]. JOURNAL OF PRACTICAL HEPATOLOGY, 2018, 21(3): 360-363.
[4]	Zhang Gaizhen，Ren Jianjun.. Lipid levels and MELD-Na scores in patients with liver cirrhosis [J]. JOURNAL OF PRACTICAL HEPATOLOGY, 2016, 19(6): 732-733.
[5]	Cen Yu，Su Sibiao，et al.. IL-22 expression and its clinical significance in patients with hepatitis B virus-induced decompensated liver cirrhosis [J]. JOURNAL OF PRACTICAL HEPATOLOGY, 2016, 19(6): 734-735.
[6]	Zhou Jing,Su Fei. Clinical features of 100 patients with acute exacerbation of cirrhosis with liver function decompensation [J]. JOURNAL OF PRACTICAL HEPATOLOGY, 2016, 19(3): 314-317.
[7]	Xiao Xiao, Yang Jun, Yan Qixian. Efficacy of TACE treatment in 53 patients with small hepatocellular carcinoma with underlying liver cirrhosis of Child-Pugh class C [J]. JOURNAL OF PRACTICAL HEPATOLOGY, 2016, 19(2): 204-207.
[8]	Cao Li, Xu Haifeng. Model for end-stage liver disease and Child-Pugh score in short-term prediction of patients with liver failure receiving plasma exchange [J]. JOURNAL OF PRACTICAL HEPATOLOGY, 2014, 17(6): 652-655.
[9]	Li Xin, He Changlun.. Clinical features of portal hypertensive gastropathy in 77 patinets [J]. JOURNAL OF PRACTICAL HEPATOLOGY, 2012, 15(5): 411-413.
[10]	ANG Fang，ZHANG Xiaogang，ZHANG Jing，et al.. The curative effect of auto-marrow stem cells in treatment fo 50 patients with decompensated liver cirrhosis [J]. JOURNAL OF PRACTICAL HEPATOLOGY, 2010, 13(4): 272-274.
[11]	SUN Lihua，FAN Xiaotang， XIAO Lin，et al.. The curative effect of plasma exchange on patients with severe hepatitis [J]. JOURNAL OF PRACTICAL HEPATOLOGY, 2010, 13(4): 278-279.
[12]	TANG Changhua, LI Zhibin, LIU Fang, et al.. The concentration of serum sodium in predicting prognosis of patients with chronic severe hepatitis B [J]. JOURNAL OF PRACTICAL HEPATOLOGY, 2010, 13(1): 31-33.